Filtros de búsqueda

Lista de obras de Annika Auranen

18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer.

artículo científico publicado en 2015

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources

artículo científico publicado en 2016

A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer.

artículo científico publicado en 2013

A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families ⬇️

artículo científico publicado el 16 de marzo de 2011

BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families

artículo científico publicado en 2001

BRCA2 arg372hispolymorphism and epithelial ovarian cancer risk

article

Borderline ovarian tumors in Finland: epidemiology and familial occurrence

artículo científico publicado en 1996

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).

artículo científico publicado en 2017

Common polymorphisms in checkpoint kinase 2 are not associated with breast cancer risk

artículo científico publicado en 2003

FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.

artículo científico publicado en 2012

Gene expression profiling of endometrial adenocarcinomas reveals increased apolipoprotein E expression in poorly differentiated tumors.

artículo científico publicado en 2009

Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum-Taxane Chemotherapy.

artículo científico publicado en 2015

Immunohistochemically detected p53 and HER-2/neu expression and nuclear DNA content in familial epithelial ovarian carcinomas

scientific article published on 01 June 1997

Is estrogen replacement therapy increasing or decreasing the risk of cancer?

artículo científico publicado en 2003

Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma.

artículo científico publicado en 2015

Polymorphisms in DNA repair genes and epithelial ovarian cancer risk

article

Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer

artículo científico publicado en 2017

Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.

artículo científico publicado en 2013

Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature.

artículo científico publicado en 2007

REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker

artículo científico publicado en 2016

Radiation therapy and biological compounds for consolidation therapy in advanced ovarian cancer

scientific article published on March 2008

Segregation analysis of epithelial ovarian cancer in Finland

artículo científico publicado en 1998

Serum HE4 Profile During Primary Chemotherapy of Epithelial Ovarian Cancer

artículo científico publicado en 2011

Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer

artículo científico publicado en 2014

The Expression of HSD17B12 Is Associated with COX-2 Expression and Is Increased in High-Grade Epithelial Ovarian Cancer

artículo científico publicado en 2018

[Cancer incidence in the first-degree relatives of ovarian cancer patients]

scientific article published on 01 January 1997

[Mesenterial fibrosis--could it be desmoidi?]

scientific article published on 01 January 2012

[Update on current care guidelines: ovarian cancer]

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda